[ET Net News Agency, 8 May 2026] TRANSTHERA-B (02617) rose 22.2% to HK$58.25.
It hits an intra-day high of HK$58.4, breaking above the 10-D SMA of HK$53.857, and an intra-day low of HK$47.4. The total shares traded was 4.51 million, with a value of HK$240.86m. The active buy/sell ratio is 62:38, with net buying turnover of HK$56.88m. HSBC SEC BRO (ASIA) accounts for greatest net responsive buying turnover of HK$393,382, with volume weighted average price of HK$51.828. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$5.42m, with volume weighted average price of HK$53.49.
Basic Information| Nominal | 58.250 | % Chg | +22.22% |
| High | 58.400 | Low | 47.400 |
| Shares Tr | 4.51m | Turnover | 240.86m |
| 10-D SMA | 53.857 | %H.V | 42.196 |
| 20-D SMA | 60.386 | VWAP | 53.390 |
| 50-D SMA | 66.820 | RSI14 | 46.024 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 62:38, with net buying turnover of HK$56.88m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| TRANSTHERA-B (02617) | 58.25 | +22.22 |
| INNOVENT BIO (01801) | 89.50 | -1.76 |
| XTALPI (02228) | 9.23 | -0.22 |
| WUXI XDC (02268) | 56.05 | -2.27 |
| WUXI BIO (02269) | 32.34 | -2.82 |
| WUXI APPTEC (02359) | 136.60 | -2.29 |
| BEONE MEDICINES (06160) | 190.90 | +1.06 |
| ZAI LAB (09688) | 15.38 | -5.06 |
| AKESO (09926) | 134.60 | -2.39 |
| REMEGEN (09995) | 99.20 | -2.27 |
(ed)
Nominal 
